Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1896 studies found for:    Open Studies | "Diabetes Mellitus"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Diabetes Mellitus"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus
Condition: Diabetes Mellitus Type 2
Intervention: Behavioral: Shared Decision Making
2 Not yet recruiting Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Evogliptin;   Drug: Sitagliptin;   Drug: Placebo Evogliptin;   Drug: Placebo Sitagliptin
3 Recruiting Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Intervention: Other: BMMCT
4 Recruiting An Exploratory Study to Evaluate the Effects of Trelagliptin and Alogliptin by CGM on Glucose Variability for One Week With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Trelagliptin;   Drug: Alogliptin
5 Recruiting Clinical Trial of Efficiency and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus
Condition: Type I Diabetes Mellitus
Interventions: Drug: Subetta;   Drug: Placebo
6 Recruiting Clinical Trial of Efficiency and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus
Condition: Type II Diabetes Mellitus
Interventions: Drug: Subetta;   Drug: Placebo
7 Not yet recruiting Use of Stem Cells in Diabetes Mellitus Type 1
Condition: Diabetes Mellitus Type 1
Intervention: Biological: Adipose mesenchymal cells with bone marrow mononuclear cells
8 Recruiting Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Albiglutide weekly injection;   Biological: Placebo weekly injection;   Biological: Insulin
9 Recruiting Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
Condition: Diabetes Mellitus Type II
Interventions: Drug: Liraglutide;   Drug: Insulin bolus;   Drug: GIK infusion
10 Recruiting Mapping Genes for Type 2 (Non-Insulin Dependent) Diabetes Mellitus
Condition: Non-Insulin Dependent Diabetes Mellitus
Intervention:
11 Recruiting A Study of Single and Multiple Doses of ORMD-0801 (Study Drug) or Placebo in Subjects With T2 (Type 2) DM (Diabetes Mellitus)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: ORMD-0801 (qd);   Drug: ORMD-0801 (bid);   Drug: ORMD-0801 (tid);   Other: Placebo
12 Not yet recruiting Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Lixisenatide;   Drug: Basal insulins
13 Recruiting Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Biological: Albiglutide 30 mg;   Biological: Albiglutide 50 mg;   Biological: Albiglutide matching placebo
14 Recruiting Role of DbXell in the Treatment of Subjects With Mildly Uncontrolled Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: DbXell;   Dietary Supplement: Placebo
15 Recruiting A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: ASP1941;   Drug: Placebo;   Other: Insulin Therapy
16 Recruiting An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada
Condition: Diabetes Mellitus, Type 2
Intervention: Other: No Intervention
17 Recruiting Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes
Condition: Diabetes Mellitus
Intervention: Other: PATH electronic decision support tool
18 Recruiting Balance After Baby Intervention for Women With Recent Gestational Diabetes
Condition: Gestational Diabetes Mellitus
Intervention: Behavioral: BABI-2 Lifestyle Intervention
19 Recruiting Exploratory Study on Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: INGAP Peptide, Ustekinumab
20 Recruiting A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ipragliflozin L-proline;   Drug: Metformin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.